Usefulness of Contrast-Enhanced Intraoperative Ultrasound Using Sonazoid in Patients With Hepatocellular Carcinoma

Junichi Arita(Akita University), Norihiro Kokudo(National Center for Global Health and Medicine), Yoshifumi Beck(The University of Tokyo), Junichi Shindoh(Toranomon Hospital), Shojiro Hata(The University of Tokyo), Yasuhiko Sugawara(Kumamoto University), Michiro Takahashi, Kiyoshi Hasegawa(University of Tokyo Hospital)
Annals of Surgery
June 21, 2011
10.1097/sla.0b013e31822518be
Cited by 71

Related Papers

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma
|Gastroenterology|2008|765
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma
|Annals of Surgery|2005|641